Available innovations

Researchers from The University of Queensland have identified adjuvants which can re-sensitise tetracycline-resistant strains of group A streptococcus and restore its activity in a skin infection model.

Commercialisation stories

Portfolio companies

TALK TO US ABOUT

IP commercialisation

Mark Ashton
Executive Director, Intellectual Property Commercialisation
Ben Phillis
Director, Asset Management
Craig Belcher
Senior Director, Commercial Engagement - Health
Tamsin Terry
Director, Commercial Engagement – Life Sciences
Stephen Earl
Director, Commercial Engagement - Therapeutics (Health)
Stephen Bradford
Associate Director, Commercial Engagement – Life Sciences
Anthony Raphael
Associate Director, Commercial Engagement - Life Sciences
Yvonne Booth
Associate Director, Commercial Engagement - Health
FIND A

UQ expert >


UniQuest has access to over 7000+ UQ researchers with research at or above world standard across 30 research strength areas